Sandostatin LAR en es it fr

Sandostatin LAR Brand names, Sandostatin LAR Analogs

Sandostatin LAR Brand Names Mixture

  • No information avaliable

Sandostatin LAR Chemical_Formula

C49H66N10O10S2.2C2H4O2

Sandostatin LAR RX_link

http://www.rxlist.com/cgi/generic2/octreotide.htm

Sandostatin LAR fda sheet

Sandostatin LAR msds (material safety sheet)

Sandostatin LAR Synthesis Reference

No information avaliable

Sandostatin LAR Molecular Weight

1138.4822

Sandostatin LAR Melting Point

No information avaliable

Sandostatin LAR H2O Solubility

No information avaliable

Sandostatin LAR State

Liquid

Sandostatin LAR LogP

No information avaliable

Sandostatin LAR Dosage Forms

Solution

Sandostatin LAR Indication

For treatment of acromegaly and reduction of side effects from cancer chemotherapy

Sandostatin LAR Pharmacology

Octreotide exerts pharmacologic actions similar to the natural hormone, somatostatin. It is an even more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Like somatostatin, it also suppresses leuteinizing hormone (LH) response to GnRH, decreases splanchnic blood flow, and inhibits release of serotonin, gastrin, vasoactive intestinal peptide, secretin, motilin, and pancreatic polypeptide. Octreotide has been used to treat the symptoms associated with metastatic carcinoid tumors (flushing and diarrhea), and Vasoactive Intestinal Peptide (VIP) secreting adenomas (watery diarrhea). Octreotide substantially reduces and in many cases can normalize growth hormone and/or IGF-1 (somatomedin C) levels in patients with acromegaly.

Sandostatin LAR Absorption

No information avaliable

Sandostatin LAR side effects and Toxicity

No information avaliable

Sandostatin LAR Patient Information

No information avaliable

Sandostatin LAR Organisms Affected

Humans and other mammals